Rice Hall James & Associates’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Buy
238,724
+584
+0.2% +$35.8K 0.59% 54
2026
Q1
$15.5M Buy
238,140
+8,118
+4% +$594K 0.87% 35
2025
Q4
$18.5M Sell
230,022
-9,265
-4% -$745K 1.02% 30
2025
Q3
$19.6M Sell
239,287
-22,045
-8% -$1.91M 1.07% 27
2025
Q2
$23.8M Sell
261,332
-2,396
-0.9% -$214K 1.28% 25
2025
Q1
$24.1M Buy
263,728
+112,070
+74% +$9.78M 1.42% 22
2024
Q4
$12.9M Sell
151,658
-15,365
-9% -$1.35M 0.71% 40
2024
Q3
$14.6M Buy
167,023
+128,919
+338% +$10.9M 0.79% 37
2024
Q2
$3.01M Sell
38,104
-2,424
-6% -$199K 0.18% 126
2024
Q1
$3.66M Buy
+40,528
New +$3.69M 0.21% 102

Other funds holding DOX

Rice Hall James & Associates's DOX Position: Q2 2026 in Review

Rice Hall James & Associates increased its Amdocs (DOX) stake by 0.25% in Q2 2026, buying an estimated $35.8K and bringing the position to 238,724 shares worth $12.1M. The position accounts for 0.59% of the portfolio, ranked #54.

Rice Hall James & Associates first reported a position in DOX in Q1 2024 and has held it in 10 quarters since. The position peaked at $24.1M in Q1 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Rice Hall James & Associates held 238,724 shares of Amdocs worth $12.1M as of Q2 2026.
  • Rice Hall James & Associates bought 584 Amdocs shares in Q2 2026, an estimated $35.8K.
  • Amdocs made up 0.59% of Rice Hall James & Associates's portfolio in Q2 2026, its #54 holding.
  • Rice Hall James & Associates first reported a position in Amdocs in Q1 2024 and has held it in 10 quarters since.
  • Rice Hall James & Associates's Amdocs position peaked at $24.1M in Q1 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.